Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Saved in:
| Title: | Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection. |
|---|---|
| Authors: | Dalai SC; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Dines JN; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Snyder TM; Adaptive Biotechnologies, Seattle, Washington, USA., Gittelman RM; Adaptive Biotechnologies, Seattle, Washington, USA., Eerkes T; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Vaney P; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Howard S; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA., Akers K; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Skewis L; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Monteforte A; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Witte PR; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Wolf C; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Nesse H; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Herndon M; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA., Qadeer J; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Duffy S; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Svejnoha E; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Taromino C; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Kaplan IM; T-Detect Product Management, Adaptive Biotechnologies, Seattle, Washington, USA., Alsobrook J; Molecular Lab Management, Adaptive Biotechnologies, Seattle, Washington, USA., Manley T; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA., Baldo L; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Dec 19; Vol. 75 (12), pp. 2079-2087. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35521791 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dalai+SC%22">Dalai SC</searchLink>; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Dines+JN%22">Dines JN</searchLink>; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Snyder+TM%22">Snyder TM</searchLink>; Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Gittelman+RM%22">Gittelman RM</searchLink>; Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Eerkes+T%22">Eerkes T</searchLink>; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Vaney+P%22">Vaney P</searchLink>; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Howard+S%22">Howard S</searchLink>; Regulatory Affairs, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Akers+K%22">Akers K</searchLink>; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Skewis+L%22">Skewis L</searchLink>; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Monteforte+A%22">Monteforte A</searchLink>; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Witte+PR%22">Witte PR</searchLink>; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Wolf+C%22">Wolf C</searchLink>; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Nesse+H%22">Nesse H</searchLink>; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Herndon+M%22">Herndon M</searchLink>; Molecular Product Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Qadeer+J%22">Qadeer J</searchLink>; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Duffy+S%22">Duffy S</searchLink>; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Svejnoha+E%22">Svejnoha E</searchLink>; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Taromino+C%22">Taromino C</searchLink>; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Kaplan+IM%22">Kaplan IM</searchLink>; T-Detect Product Management, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Alsobrook+J%22">Alsobrook J</searchLink>; Molecular Lab Management, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Manley+T%22">Manley T</searchLink>; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Baldo+L%22">Baldo L</searchLink>; Medical Affairs and Clinical Development, Adaptive Biotechnologies, Seattle, Washington, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2022 Dec 19; Vol. 75 (12), pp. 2079-2087. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35521791 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciac353 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2079 Titles: – TitleFull: Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dalai SC – PersonEntity: Name: NameFull: Dines JN – PersonEntity: Name: NameFull: Snyder TM – PersonEntity: Name: NameFull: Gittelman RM – PersonEntity: Name: NameFull: Eerkes T – PersonEntity: Name: NameFull: Vaney P – PersonEntity: Name: NameFull: Howard S – PersonEntity: Name: NameFull: Akers K – PersonEntity: Name: NameFull: Skewis L – PersonEntity: Name: NameFull: Monteforte A – PersonEntity: Name: NameFull: Witte PR – PersonEntity: Name: NameFull: Wolf C – PersonEntity: Name: NameFull: Nesse H – PersonEntity: Name: NameFull: Herndon M – PersonEntity: Name: NameFull: Qadeer J – PersonEntity: Name: NameFull: Duffy S – PersonEntity: Name: NameFull: Svejnoha E – PersonEntity: Name: NameFull: Taromino C – PersonEntity: Name: NameFull: Kaplan IM – PersonEntity: Name: NameFull: Alsobrook J – PersonEntity: Name: NameFull: Manley T – PersonEntity: Name: NameFull: Baldo L IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 12 Text: 2022 Dec 19 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 75 – Type: issue Value: 12 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |